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Background: We sought to define the sensitivity and specificity of intraperitoneal (IP) and intraluminal (IL)
microdialysate metabolites in depicting ex vivo small intestinal total ischemia during GI-tract surgery. We
hypothesized that IL as opposed to IP microdialysis detects small intestinal ischemia with higher sensitivity
and specificity.
Methods: IL and IP microdialysate lactate, pyruvate, glucose and glycerol were analysed from small intestine of
pancreaticoduodenectomy patients before and after occluding the mesenteric vasculature and routine resection of
a segment of small intestine. Ex vivo time sequences of microdialysate metabolites were described and ROC
analyses after 0–30, 31–60, 61–90 and 91–120 minutes after the onset ischemia were calculated.
Results: IL lactate to pyruvate ratio (L/P ratio) indicated ischemia after 31–60 minutes with 0.954 ROC AUC
(threshold: 109) in contrast to IP L/P (ROC AUC of 0.938 after 61–90 minutes, threshold: 18). At 31–60 minutes IL
glycerol concentration indicated ischemia with 0.903 ROC AUCs (thresholds: 69 μmol/l). IP glycerol was only
moderately indicative for ischemia after 91–120 minutes with 0,791 ROC AUCs (threshold 122 μmol/l). After
31–60 minutes IL and IP lactate to glucose ratios (L/G ratio) indicated ischemia with 0.956 and 0,942 ROC AUCs
(thresholds: 48,9 and 0.95), respectively.
Conclusions: The results support the hypothesis that intraluminal application of microdialysis and metabolic
parameters from the small intestinal lumen indicate onset of ischemia earlier than intraperioneal microdialysis with
higher sensitivity and specificity.
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Microdialysis enables the researcher or the clinician to
investigate local tissue metabolism and to detect insuffi-
cient perfusion of a selected tissue [1-6]. Intestinal appli-
cation of the method has been tested in several different
experimental settings while clinical investigations are
still scarce. Intramural [7,8], intraluminal [9-12] or intra-
peritoneal [1,3-6,9,11,13] location of microdialysis cathe-
ters has been suggested by different investigators.
While intramural microdialysis may be the ideal me-
thod in terms of supplying signal from the interstitium* Correspondence: jyrki.tenhunen@surgsci.uu.se
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reproduction in any medium, provided the orwithin the wall of intestine, the invasive nature of this
approach limits its clinical application, as the placement
of the probe causes surgical trauma and affects the local
metabolism up to 1 h [9]. Either intraluminal or intrape-
ritoneal (gut serosal) access might serve as a surrogate
for metabolic signal from intestinal cells. In particular,
intraluminal release of metabolic markers putatively re-
flects the status of intestinal epithelial cells [7]. It is rea-
sonable to assume that metabolite release to the lumen
of gut is either spill over from the deeper tissue or di-
rectly from intestinal epithelial cells.
It has been postulated that gut may serve not only as a
target organ to, but indeed a source of systemic inflam-
mation by releasing bacteria or toxins to blood or lymph
(gut hypothesis). Therefore it is rational to hypothesize
that the viability of intestinal epithelial cells is the logicaltral Ltd. This is an open access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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tion [7,9,14-19].
High lactate and the lactate-to-pyruvate ratio or gly-
cerol release to the bowel lumen are considered as early
and specific markers of the damage of the gut epithelial
cells [8,9,12,14]. Alternatively, the oxygenation/metabol-
ism of the gut wall can be measured intraperitoneally
(inside the abdominal cavity against the serosal surface
of the gut) ((animal studies; 1, 9, 11, 13, human studies;
3, 4, 5, 6)). This approach obviously is farther from the
intestinal epithelial cells and therefore might describe a
different aspect of gut viability. A direct comparison of
the two approaches in clinical setting is lacking.
Our purpose was to determine which localisation for
the microdialysis catheter enables the monitoring of gut
wall metabolism with high sensitivity and specificity to
depict gut wall ischemia.
In addition, because as early signal as possible is nee-
ded to alert the clinician for the adverse event, the time
sequence of the signals was analysed. To the best of our
knowledge, there is no clinical report on the comparison
between intraperitoneal and intraluminal microdialysis.
We specifically hypothesized that intraluminal micro-
dialysis offers earlier and more sensitive signal for ische-
mic gut.
Methods
This was an observational, prospective non-interventional
trial and therefore it was not listed in Clinical Trials.gov.
The study was approved by the institutional ethical review
board of Tampere University Hospital, Finland.
Twenty patients scheduled for elective pancreatic car-
cinoma surgery in the Tampere University Hospital were
enrolled into this study after informed consent proce-
dure. Inclusion criteria were the patient’ age > 17 years
of age and need for pancreaticododenectomy (Whipple’s
procedure). Whipple procedure patients were chosen as
surgically and ethically suitable group of patients since
the Whipple specimen that is removed during the oper-
ation includes a segment of (healthy) jejunum that can
be used for not only pathology analyses but also for a
total gut ischemia model ex vivo. Exclusion criteria were
a pre-existing inflammatory bowel disease or prior en-
rolment to any interventional trial within 30 days prior
to this study.
Anaesthesia was induced according to in house pro-
tocol by boluses of propofol (Propofol Fresenius Kabi
(10 mg/ml), Fresenius Kabi Ab, GER) and Fentanyl
(Fentanyl (50 μg/ml) Janssen-Cilag Oy, SWZ). Neuromus-
cular blockage was induced by cis-atracurium (Nimbex,
(5 mg/ml) GlaxoSmithKline, UK). Anaesthesia was main-
tained by infusion of remifentanyl (Ultiva (100 mg/ml),
GlaxoSmithKline, UK) and inhaled sevofluran (Sevorane,
Abbott Scandinavia AB, SWE), the muscle relaxation wasadded as needed according to Train-of-Four measure-
ment. Adequate intravascular volume and systemic ar-
terial blood pressure was maintained using NaCl 0,9%
and/or Ringer 1000 infusions and infusion of noradrenalin
(Levophed (1 mg/ml) Hospira, UK) if needed.
Surgical method in brief: The same team of surgeons
performed each operation (JSa, SRä, INo). Through a bi-
lateral subcostal laparotomy, after inserting the two first
microdialysis catheters into the gut lumen (intraluminal)
and on the serosal surface (intraperitoneal, antemesen-
terial pouch was prepared by superficial serosal sutures
for the catheter) of the segment down stream of liga-
ment of Treitz in jejunum was visualized, prepared and
resected as part of final Whipple specimen. While the
abdominal exploration, segment visualization and prepa-
ration, the baseline samples were collected.
Microdialysis – combination of in vivo and ex vivo
validation
Two catheters, intraluminal and serosal/intraperitoneal,
(CMA 62 gastrointestinal microdialysate catheter® dia-
meter 0,6 mm, length 30 mm) were placed in the part of
the jejunum that was later resected as standard proce-
dure in Whipple operation. No additional preparations
or resections were performed. Immediately following the
laparotomy intraluminal microdialysis catheter was in-
troduced to the lumen of intestine through an anteme-
senterical opening and sutured. The other catheter was
placed on the serosal surface of the intestine and su-
tured. Set of superficial sutures were then applied to
form a tunnel/pouch for the serosal/intraperitoneal
catheter to ensure contact against serosa to mimic free
placing between the intestines in intraperitoneal micro-
dialysis. The catheters were connected to two CMA 107®
pumps (CMA-Microdialysis, Stockholm, Sweden), with a
flow rate of 1 μL/min. Microdialysate sampling was ad-
justed according to dead space in the outflow tubing and
taking into account the microdialysate flow rate. Ten-
minute fractions were collected over the length of the
experiment, thus the aim was to collect 3 samples per
patient per one thirty-minute interval after the baseline
(in vivo) pre-ischemic samples. Pre-ischemic baseline
samples during the surgical procedure were collected
prior to clamping the vasculature of the segment. Each
pre-ischemic period lasted 20–30 minutes. Therefore
2–3 baseline samples were obtained for baseline me-
tabolic state of intestinal wall. A jejunal segment of
4–6 cm in length was removed from the Whipple speci-
men, before relocating the bowel and its’ mesenterium
together with superior mesenteric artery and vein supply
to right upper abdomen as per surgical protocol. The
time of the removal of the resecate was registered, the
timing of microdialysate sampling adjusted accord-
ingly. The microdialysate samples were gathered up to
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removed bowel segment (ischemic stage/ex vivo). The
resected part of small intestine was placed in a sterile cup
within a warm closed water bath. The resected intestine
was not in direct contact with water. The temperature was
kept constant at 37–38 degrees of Centigrade during the
ex vivo experimentation.
Dead space volume (with 7 minutes delay under 1 μL/
min flow rate) of the microdialysate outflow tubing was
accounted for by adjusting the sample collection accord-
ing to events in surgery. The recovery rate of analytes to
microdialysate was assumed high enough for adequate
analyses. While the recovery rate can be assumed less
than optimal with 1 μL/min, the decision on the flow
rate was made based on the need for short (10-minute)
collection time per sample and to standardized sample
collection intra- and inter-individually. All the micro-
dialysate samples were then frozen (−20°C) for later
analyses. Samples were analyzed using CMA 600® Mi-
crodialysis Analyzer (CMA-Microdialysis, Stockholm,
Sweden) in a batch after storage.
During the surgery arterial blood gas analyses were per-
formed at the beginning of the surgery and at the begin-
ning of the local ischemia (mesenteric arterial occlusion).
Calculations and statistical analyses
All data were calculated using SPSS for Windows, version
17.0 (SPSS Inc., Chicago, IL, USA). Results are expressed
as median (quartiles) unless otherwise indicated. Receiver
Operating Characteristics (ROC) analysis was performed
for lactate/pyruvate ratio, glycerol, and lactate/glucose
ratio at four time segments of the ex vivo experiment:
0–30 minutes, 31–60 minutes, 61–90 minutes and
91–120 minutes after occluding the mesenteric vessels im-
mediately prior to gut resection. The highest area under
the curve (AUC) value and the best threshold value is
given. The best threshold value is reported as the closest
to (0,1) point value. As the data were not normally dis-
tributed (Kolmogorov-Smirnov), in line with the descrip-
tive statistics, non-parametric tests Mann–Whitney U and
Wilcoxon’s Signed rank tests were used. P < 0.05 was con-
sidered statistically significant.
Results
A total of 21 patients (10 females and 11 males) with
the age of 66 (56–71) years were enrolled after writtenTable 1 Hemodynamics in the beginning of the surgery and i
Hemodynamics
pH n gluc (mmol/l) n Lact (mmol/l)
In the beginning
of the surgery
7,42 (7,39–7,44) 18 6,55 (5,98–7,15) 18 0,7 (0,5–0,85)
Before ischemia 7,39 (7,38–7,46) 13 6,9 (5,93–7,53) 14 0,7 (0,6–1,28)
Values are means (quartiles).informed consent. One patient was excluded because
technical failure of microdialysis catheters. The systemic
hemodynamics and metabolic conditions were stable du-
ring to the surgery prior to the beginning of the local gut
ischemia (Table 1).
Lactate/pyruvate ratio
Pre ischemic L/P- ratio was 16 (10–51) intraluminally
and 14 (from 8–18) intraperitoneally with lactate con-
centrations of 0.1 (0.03- 0.4) mM and 0.7 (0.2– 1.5) mM,
respectively. Intraluminal microdialysate L/P ratio in-
creased to its maximum of 88-fold (at 31–60 minutes) in
comparison to maximum of 15-fold increase intraperito-
neally (91-120 minutes) during the 120 minutes of ob-
servation (Figure 1a). Intraluminal L/P ratio indicated
gut ischemia after 31–60 minutes after onset of ischemia
(ROC AUC of 0.954) with 96% sensitivity and 89% speci-
ficity with the threshold L/P ratio of 109. Intraperitoneal
L/P ratio indicated gut ischemia at 61–90 minutes after
onset of ischemia (ROC AUC of 0.938) with 97% sensi-
tivity and 80% specificity with threshold L/P ratio of 18
(Figure 2 and Table 2).
Glycerol
Intraluminal pre-ischemic glycerol was 9 (from 4–37)
μmol/l and intraperitoneal 107 (20–145) μmol/l. Ische-
mia increased markedly the intraluminal concentrations;
intraluminal microdialysate glycerol increased to the
maximum of 211-fold (at 61–90 minutes) in comparison
to a 1.9-fold increase intraperitoneally (Figure 1b). In-
traluminal glycerol indicated gut ischemia at 31–60
minutes after onset of ischemia (ROC AUC of 0.903)
with sensitivity of 87% and specificity of 89% with thre-
shold of 58 μmol/l. In the last time segment (91–120
minutes after onset of ischemia) ischemia was authenti-
cated (ROC AUC of 0.950) with sensitivity of 93% and
specificity of 87% by threshold of 50 μmol/l intraluminally.
Intraperitoneal glycerol was moderately indicative for
ischemia (ROC AUC of 0.791); intraperitoneal thresh-
old level was in all the time segments comparable
(109–122 μmol/l) and maximum sensitivity and speci-
ficity were below 77% (Figure 2 and Table 2).
Lactate/glucose ratio
Baseline intraluminal L/G ratio was 2 (from 1 to 12) and
intraperitoneal 0.2 (from 0.1 to 0.4). During ischemia,n the beginning of the ischemia
n Sa (%) n MAP n pulse n CVP n
18 99 (98–100) 20 70 (63,5–81,5) 20 68 (56–75) 20 9 (7–11) 19
12 100 (99–100) 20 74 (65,75–78) 20 64 (55–70) 20 7 (7–9) 19
a b c
Figure 1 Intraluminal and intraperitoneal microdialysate metabolite signals during the baseline and four ischemia periods. a.
Intraluminal and intraperitoneal lactate to pyruvate ratios during baseline and four ischemic time periods measured by microdialysis. b. Intraluminal
and intraperitoneal glycerol (μmol/l) during baseline and four ischemic time periods measured by microdialysis. c. Intraluminal and intraperitoneal
lactate to glucose ratios during baseline and four ischemic time periods measured by microdialysis.
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inally. Maximum intraperitoneal increase of 863-fold oc-
curred during 90–120 minutes after onset of ischemia.
The maximum increase intraluminally was 63-fold du-
ring the second ischemic time segment, between 31–60
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Figure 2 ROC- curves for intraluminal and intraperitoneal lactate to pMetabolic signal by L/G ratio from both locations in-
dicated ischemia after 30 minutes; Intraluminally (ROC
AUC 0.956) sensitivity was 89% and specificity of 96%
with threshold of 49 and intraperitoneally (ROC AUC
0.942) sensitivity was 90% and specificity of 93% with
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Table 2 Intraluminal and Intraperitoneal sensitivity, specificity, threshold and AUC - values for detecting ischemia in
human gut by lactate to pyruvate ratio, glycerol and lactate to glucose ratio
Intraluminal Intraperitoneal
Minutes after ischemia Minutes after ischemia
1–30 Threshold level Sensitivity Specificity AUC* 1–30 Threshold level Sensitivity Specificity AUC*
18.95 73.30% 63%
L/P 22.35 70.00% 66.70% L/P 15.37 63.00% 56.40%
28.79 66.70% 66.70% 0.695 18.59 60.90% 79.50% 0.673
19.54 58.70% 79.50%
Glycerol μmol/l 19.78 67.50% 60.90% Glycerol μmol/l 100.61 68.10% 48.90%
20.07 65.00% 60.90% 0.701 108.70 66.00% 55.30% 0.584
20.49 65.00% 63.00% 114.73 57.40% 57.40%
L/G 1.75 73.90% 39.30% L/G 0.38 70.80% 79.10%
3.75 60.90% 60.70% 0.634 0.41 68.80% 81.40% 0.78
7.59 43.50% 67.90% 0.44 64.60% 81.40%
Minutes after ischemia Minutes after ischemia
31–60 Threshold level Sensitivity Specificity AUC 31–60 Threshold level Sensitivity Specificity AUC
L/P 68.49 96.00% 85.20% L/P 31.27 76.90% 92.30%
109.42 96.00% 88.90% 0.954 35.95 76.90% 94.90% 0.800
137.51 92.00% 88.90% 37.72 74.40% 94.90%
Glycerol μmol/l 58.27 87.00% 89.10% Glycerol μmol/l 103.22 62.20% 51.10%
68.71 87.00% 91.30% 0.903 108.92 60.00% 55.30% 0.593
79.13 85.20% 91.30% 114.52 53.30% 57.40%
L/G 40.50 88.90% 92.90% L/G 0.76 89.50% 90.70%
48.90 88.90% 96.40% 0.956 0.95 89.50% 93.00% 0.94
57.40 85.20% 96.40% 1.04 86.80% 93.00%
Minutes after ischemia Minutes after ischemia
61–90 Threshold level Sensitivity Specificity AUC 61–90 Threshold level Sensitivity Specificity AUC
L/P 52.77 100.00% 81.50% L/P 18.27 96.60% 79.50%
68.49 100.00% 85.20% 0.996 23.87 93.10% 87.20% 0.938
131.40 100.00% 88.90% 31.27 89.70% 92.30%
Glycerol μmol/l 28.82 80.40% 67.40% Glycerol μmol/l 102.02 74.30% 48.90%
39.02 80.40% 80.40% 0.897 116.69 71.40% 61.70% 0.700
58.27 80.40% 88.10% 125.57 62.90% 66.00%
L/G 36.50 88.50% 89.30% L/G 0.46 95.20% 81.40%
46.50 88.50% 96.40% 0.974 0.76 95.20% 91.70% 0.97
58.40 80.80% 100.00% 1.97 95.20% 93%
Minutes after ischemia Minutes after ischemia
91–120 Threshold level Sensitivity Specificity AUC 91–120 Threshold level Sensitivity Specificity AUC
L/P 27.78 100.00% 66.70% L/P 19.11 85.70% 79.50%
41.13 100.00% 70.40% 0.989 27.17 85.70% 89.70% 0.860
52.77 100.00% 81.50% 31.22 75.00% 92.30%
Glycerol μmol/l 40.47 92.70% 82.60% Glycerol μmol/l 115.61 76.50% 59.60%
49.55 92.70% 87.00% 0.950 122.43 76.50% 63.80% 0.791
58.27 92.70% 89.10% 145.27 70.60% 76.60%
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Table 2 Intraluminal and Intraperitoneal sensitivity, specificity, threshold and AUC - values for detecting ischemia in
human gut by lactate to pyruvate ratio, glycerol and lactate to glucose ratio (Continued)
L/G 28.50 95.20% 85.70% L/G 0.46 100.00% 81.40%
36.50 95.20% 89.30% 0.971 1.97 100.00% 93.00% 0.99
47.50 95.20% 96.40% 5 100% 97.7 %
*AUC, area under the curve in receiver operating characteristics (ROC) analysis.
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and 91–120 minutes) between 88 to 100% and sensitivity
between 89 to 100% (Figure 2 and Table 2).
Discussion
The main finding of the present prospective study was
that ischemia was detectable 31–60 minutes after the
onset of ischemia with high ROC AUC (high sensitivity
and specificity) for all three metabolic endpoints intra-
luminally. Intraperitoneal microdialysate metabolic pa-
rameters indicated ischemia either with lower ROC AUC
(lower sensitivity and/or specificity) or later as compared
to intraluminal location.
This is to our knowledge the first clinical trial where
intraluminal and intraperitoneal microdialysis has been
directly compared. In addition, this is the first trial to re-
port sensitivity and specificity (ROC analysis) of each
metabolic signal to depict gut ischemia. Intraluminal mi-
crodialysate metabolites reflected total gut ischemia ear-
lier and with higher sensitivity and specificity herein. On
the other hand, this was an ex vivo test of total gut is-
chemia. In clinical setting one may speculate if there is a
need to monitor potential local ischemia as opposed to
global intestinal ischemia. It is reasonable to speculate
that intraluminal microdialysis sampling reflects topi-
cal metabolism of the gut wall while intraperitoneal
microdialysis may reflect intestinal perfusion and me-
tabolism from further away from the position of the
catheter [1,5,6].
Lactate to pyruvate ratio
Normal intraperitoneal L/P ratio in patients after non-
complicated gastrointestinal surgery is known to be un-
der 15 [3] and still regarded as normal when under 20
whereas the ratio being over 20 depicts hypoxia in both
splanchnic [4] and central nervous system [20]. Herein
intraperitoneal L/P ratios were comparable. To the best
of our knowledge this is the first clinical study to report
normal small intestinal intraluminal L/P ratio.
Intraluminal L/P ratio increased earlier and with higher
ROC AUC as opposed to intraperitoneal location. Intra-
luminal L/P ratio can be affected by hypermetabolism
[1,5] and severe systemic lactatemia [14], and has to be
taken under consideration when interpreting the mi-
crodialysis results if studied in patients. On the other
hand, intraluminal lactate is not confounded by systemichyperlactatemia unless severe [14]. Systemic arterial hy-
perlactatemia on the other hand is a late sign of intes-
tinal ischaemia as the hepatic lactate uptake increases
in response to hepatic lactate influx [1]. Previously a
close correlation of ischemia induced increased intes-
tinal permeability and gut luminal lactate concentra-
tion has been proven [8].
Glycerol
In the present study intraperitoneal baseline glycerol
was of the same magnitude as normal values determined
on patients after non-complicated gastrointestinal sur-
gery, 100 μM [3,5]. Human small intestinal luminal gly-
cerol has not been reported previously. In experimental
ischemia-reperfusion both luminal and intraperitoneal
glycerol increase denotes ischemia [11].
Glycerol is released when degradation of the double
layer phospholipid membrane due to cell damage occurs.
The damage of the epithelium in the bowel wall caused
by ischemia has been studied microscopically [11] and
by microdialysis [7,9-11] using glycerol as a marker of
the damage and there is a discussion of glycerol poten-
tially being even better biomarker for detecting ischemia
compared to lactate. In addition to ischemia and trauma,
anesthetics can affect the glycerol levels as well. Propofol
fat emulsion contains glycerol and halothane is known
to increase lipolysis and plasma levels of glycerol, lactate
and glucose [1], thus having to take under considera-
tion when interpreting the microdialysis results. In the
present study propofol was used for the induction of
anesthesia.
Glycerol release from the gut epithelial cells in total
intestinal ischemia has been proven to be detectable
using microdialysis either in the intestinal wall or lumen
[8-12] and in the peritoneum [1,3,5]. Lumen has been
suggested to be preferred place for microdialysate cath-
eter [11]. Experimental intestinal ischemia does not alter
the arterial glycerol levels [11].
In a porcine model of intestinal ischemia the steady
state (non ischemic) intraperitoneal glycerol concentra-
tions were much higher and it took 100 min from
the ignition of ischemia for the increase of glycerol
levels to be statistically significant when compared to
non-ischemic values [9]. In this study the intraperito-
neal glycerol levels were not affected by ischemia to
large extent.
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Normal values for glucose varies depending of the study
and study model (human/animal). Normal mean value
for intraperitoneal glucose studied on humans after non-
complicated gastrointestinal surgery is around 8 mM [3].
In porcine studies levels are lower; 0.91 [7], 2.05 mM
[13] 3.2 mM [9] and 4.0 mM [8]. In the resting intestine
(intraluminal) glucose has not been detected suggesting
the level is extremely low [9]. Normal human intestinal
(colon) luminal glucose has been previously reported in
one trial [21]. Luminal glucose varied between 0 and
0.5 mmol/L. Small intestinal luminal glucose or lactate
to glucose ratio has not been previously described.
Ischemia causes decrease in the in the interstitial glu-
cose level in the jejunal wall [8,9,13] and in the perito-
neum [9,13] and it seems that the peritoneal levels are
less affected than those in the jejunal wall [13]. As the
blood flow is cut of the delivery of glucose decreases.
Due to the ischemia metabolism changes from aerobic
to anaerobic causing accelerated uptake of extracellular
glucose decreasing the level further on to sustain the
energetically inefficient anaerobic glycolysis. In clinical
in vivo setting transient increase in the glucose concen-
tration occurs possibly due to additional glucose delivery
source or a drop in metabolism or compensatory autore-
gulatory responses as speculated by Deeba and col-
leagues [21].
There are limitations to our investigation. It is reason-
able to assume that the state of single part of the bowel
does not predict the state of another part in terms of
circulation and metabolism. Heterogeneous perfusion
patterns have been described earlier in different dis-
ease models. Therefore it is of necessity to develop non-
invasive methods that reliably describe events in different
parts of the gastrointestinal tract. On the other hand,
in certain surgical procedures post-operative monitoring
may be aimed at specific locations such as anastomosis
area. While we state here that the localisation of the two
catheters were intraluminal and intraperitoneal, it should
be noted that the papers describing intraperitoneal appli-
cation previously applied the catheter in such manner that
the catheter collected samples of intraperitoneal fluid with
the contribution of parietal peritoneum as well. In clinical
scenario not only the mesenteric circulation affects the
constitution of peritoneal fluid but also the uptake and re-
lease of substances by the parietal peritoneum. Herein, the
catheter was enveloped between the serosal surfaces of the
antemesenteric part of the small intestine. Therefore only
gut serosal wall had an impact on the metabolite con-
centrations. Finally, we chose to use 1 microliter/min di-
alysate perfusion rate in order to obtain adequate sample
volume per short time fragment. This may have impact to
glycerol concentration obtained from the two locations
in the present experiment. Therefore the absolute uppernormal threshold may vary between trials. Conversely, lac-
tate to pyruvate ratio and lactate to glucose ratio is not
confounded by the dialysate perfusion rate since the re-
covery rate of glucose and lactate to the dialysate can be
considered comparable. Thus L/P ratio and L/G ratios can
be translated comparable to reports with microdialysis
with other perfusion rates.
Conclusions
The results support the hypothesis that intraluminal ap-
plication of microdialysis and metabolic parameters from
the small intestinal lumen indicate onset of ischemia
earlier with higher sensitivity and specificity.
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